A Phase II Clinical Study of Cadonilimab (AK104) Combined With Chemotherapy in the Treatment of PD-1 Inhibitor Resistant Nasopharyngeal Carcinoma
Latest Information Update: 08 Jan 2025
At a glance
- Drugs Cadonilimab (Primary) ; Capecitabine (Primary) ; Cisplatin; Lobaplatin; Paclitaxel
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 05 Apr 2023 New trial record